Pfizer Inc.

Nearly two-thirds of U.S. states were in a danger zone of coronavirus spread and six reported a record one-day increase in deaths on Wednesday while the pandemic's resurgence in Europe strained hospitals.

The United States is likely to have enough safe and effective COVID-19 vaccines available to inoculate the most vulnerable Americans by the end of 2020, Health and Human Services Secretary Alex Azar said on Wednesday.

Pfizer Inc <PFE.N> and BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against the coronavirus.

Asian markets advanced toward a recent 2-1/2-year peak on Monday powered by hopes of a U.S. fiscal package and expectations of a coronavirus vaccine by the end of this year, though gains were held back by weaker-than-expected Chinese economic data.

Asian markets advanced toward a recent 2-1/2-year peak on Monday powered by hopes of a U.S fiscal package and expectations of a coronavirus vaccine by the end of this year, though weaker-than-expected Chinese data capped gains.

Asian markets started higher on Monday, buoyed by hopes of a U.S fiscal package before the U.S. presidential elections next month and expectations of a coronavirus vaccine by the end of this year, though the mood was still cautious as infections jump.

Pfizer Inc <PFE.N> said on Friday it could file in late November for U.S. authorization of the COVID-19 vaccine it is developing, suggesting that a vaccine could potentially be available in the United States by the end of the year.

* Chilean peso up after central bank leaves rates unchanged * Argentina central bank lowers Leliq rate to 36% * Mexican peso outperforms Latam peers for the week (Updates prices throughout) By Shreyashi Sanyal Oct 16 (Reuters) - Latin American currencies rose on Friday after...

* Chilean peso up after central bank leaves rates unchanged * Argentina central bank lowers Leliq rate to 36% * Mexican peso outperforms Latam peers for the week By Shreyashi Sanyal Oct 16 (Reuters) - Latin American currencies rose on Friday after Pfizer said it could apply...

U.S. stocks opened higher on Friday as Pfizer said it could apply for emergency use of its COVID-19 vaccine candidate as early as November and data showed stronger-than-expected retail sales growth last month.

* PFIZER SAYS AN OPEN LETTER FROM PFIZER CHAIRMAN AND CEO ALBERT BOURLA

Pfizer Inc said on Friday it would apply for emergency use in the United States of its COVID-19 vaccine candidate being developed along with Germany's BioNTech SE as soon as a safety milestone is achieved in the third week of November. (Reporting by Manojna Maddipatla in...

Moderna Inc said on Tuesday Canada's health ministry will review its experimental COVID-19 vaccine in real time, becoming the third vaccine maker to be accepted by the country for the process that may speed up approval.

Pfizer Inc will enroll participants as young as 12 in its large, late-stage COVID-19 vaccine trial to understand how it works in a wider age group.

Pfizer Inc will enroll participants as young as 12 in its large, late-stage COVID-19 vaccine trial to understand how it works in a wider age group.

Mexican Foreign Minister Marcelo Ebrard said on Tuesday that Mexico has an agreement with pharmaceutical company Pfizer for up to 34.4 million vaccines against COVID-19.

The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc <PFE.N> and Germany's BioNTech <22UAy.F>, with delivery potentially as early as the first quarter of 2021.

Health Canada will start a real-time review of Germany's BioNTech SE and Pfizer Inc's experimental COVID-19 vaccine, the companies said on Friday.

Pfizer Inc and Germany's BioNTech SE said on Friday they have started a rolling submission to Health Canada for their experimental COVID-19 vaccine.